Price of pomalidomide 4mg strength

Pomalidomide (Pomalidomide) is an important immunomodulator in the field of multiple myeloma (MM) and its usage rate continues to increase around the world. Its 4mg strength is one of the most common dosage forms in clinical practice and is also the cost range that patients are most concerned about. Although pomalidomide has been marketed in China and included in medical insurance, the actual out-of-pocket amount still varies significantly in different regions, hospitals, and reimbursement policies. Therefore, when understanding the price, it is necessary to distinguish between the original drug, the price after medical insurance, and overseas alternative channels to provide patients with a clearer reference.

In the domestic market, pomalidomide is an imported original drug and quickly entered the medical insurance catalog after being launched, reflecting its importance in the multiple myeloma treatment system. The unreimbursed price of original research drugs is relatively high, and the reimbursement ratio of medical insurance may vary widely due to different local policies. For example, the medical insurance payment standards in first-tier cities and some provincial hospitals are different, and the actual out-of-pocket amount paid by patients will also change with the hospital grade and drug proportion management method. Due to differences in updates to the medical insurance directory and regional economic conditions, the most direct way to know the exact cost is to consult the local hospital pharmacy or medical insurance window to obtain the latest policies and individual reimbursement ratios.

In contrast, the price system in overseas markets is not consistent with that in China. In some countries, due to drug pricing policies and patent time differences, the overseas price of original pomalidomide is higher than that in China, while in other regions, the price is lower due to market competition and different medical insurance coverage. Especially in regions such as Laos and India that allow the production of generic drugs, generic versions of pomalidomide with identical ingredients have appeared on the market. The more well-known is the 4mg product produced in Laos, which is sold in the range of more than 300 yuan (the price will fluctuate with international exchange rates). This price is significantly different from that of domestic original drugs, providing an additional option for some patients with limited financial affordability.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide